Transarterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Prognostic Factors in a Single-Center Study of 188 Patients

Table 2

Predictors for survival after TACE in multivariate analysis.

Variables	Multivariate analysis
	HR	95% CI	𝑃
Total bilirubin	1.007	0.994–1.021	0.300
Child-Pugh class (class A versus class B)	2.981	1.919–4.631	<0.001
Type of PVTT; (Type I versus Type II)	2.806	2.024–3.890	<0.001
Number of tumor lesions (≥3 versus <3)	2.288	1.634–3.203	<0.001
Extrahepatic metastasis; (yes versus no)	1.909	1.157–3.149	0.011

TACE: transarterial chemoembolization; BCLC: Barcelona Clinic Liver Cancer; CI: confidence interval; HR: hazard ratio.